Article Details

Xalud Therapeutics Doses First Patient in Phase 2a Trial of XT-150 for the Treatment of ... - BioSpace

Retrieved on: 2022-03-02 14:07:52

Tags for this article:

Click the tags to see associated articles and topics

Xalud Therapeutics Doses First Patient in Phase 2a Trial of XT-150 for the Treatment of ... - BioSpace. View article details on hiswai:

Excerpt

“We believe that restoring immune system homeostasis at the site of inflammation ... Xalud Therapeutics is a biotechnology company developing a ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up